Shinohara M, Kurokawa H, Yoshihara Y, Kokubu S, Kusano T, Horie K, Murakami N, Nagai K, Nara N
Clinical Laboratory, Tokyo Medical and Dental University Hospital, Bunkyo-ku.
Rinsho Byori. 1997 Feb;45(2):179-84.
Studies on responses to surgical stress in blood coagulation and fibrinolysis, platelet counts and thromboxane B2 (TXB2) were carried out with 18 esophageal cancer patients who had undergone radical esophagectomy through right thoracotomy and reconstruction with gastric tube. Plasma levels were measured for the following for coagulation assessment: thrombin.antithrombin III complex (TAT), soluble fibrin monomer complex(SFMC), fibrinogen, antithrombin III, protein C and thrombomodulin. Selected fibrinolytic markers are: tissue plasminogen activator.plasminogen activator inhibitor 1 complex (tPA.PAI1C), plasminogen, alpha 2 plasmin inhibitor, plasmin. alpha 2 plasmin inhibitor complex(PIC), FDP and D-dimer. Peripheral venous blood samples were taken from the patients before the operation, immediately after the operation and on each of the first, second, third, seventh and fourteenth day after the operation. It was observed that TAT, SFMC, tPA.PAI-1C and TXB2 were remarkably altered immediately after the operation. This indicates that the major surgical stress significantly activated coagulation, fibrinolysis and platelets. Higher plasma levels of TAT compared to the pre-operation level was recorded for two weeks after the operation. Furthermore, in four cases, SFMC became positive during three to seven days after operation. These facts indicate that the activation of coagulation persisted during the days after operation. PIC began to increase from the 2nd to 3rd days after operation, reaching the maximum on the 7th day. Biphasic changes which peaked twice on the 1st and 7th days after operation were shown in plasma levels of FDP and D-dimer. These results indicate that the activation of fibrinolysis also persisted during the days after operation. The activation of coagulation and fibrinolysis may persist at least for two weeks after major surgical operation. Careful observation for the states of these systems was thought to be needed during the post-operative days, and the molecular markers could be useful to assess subclinical changes of these systems.
对18例经右胸径路行根治性食管切除术并采用胃管重建的食管癌患者进行了凝血、纤溶、血小板计数及血栓素B2(TXB2)对手术应激反应的研究。检测血浆中以下物质用于凝血评估:凝血酶-抗凝血酶III复合物(TAT)、可溶性纤维蛋白单体复合物(SFMC)、纤维蛋白原、抗凝血酶III、蛋白C和血栓调节蛋白。选定的纤溶标志物有:组织型纤溶酶原激活物-纤溶酶原激活物抑制剂1复合物(tPA-PAI1C)、纤溶酶原、α2纤溶酶抑制剂、纤溶酶-α2纤溶酶抑制剂复合物(PIC)、FDP和D-二聚体。于术前、术后即刻以及术后第1、2、3、7和14天采集患者外周静脉血样本。观察到术后即刻TAT、SFMC、tPA-PAI-1C和TXB2显著改变。这表明主要手术应激显著激活了凝血、纤溶和血小板。术后两周内记录到TAT血浆水平高于术前水平。此外,4例患者术后3至7天SFMC呈阳性。这些事实表明术后数天内凝血激活持续存在。PIC术后第2至3天开始升高,第7天达到最高值。FDP和D-二聚体血浆水平呈现术后第1天和第7天出现两次峰值的双相变化。这些结果表明术后数天内纤溶激活也持续存在。 major手术操作后凝血和纤溶激活可能至少持续两周。术后数天需要仔细观察这些系统的状态,分子标志物可能有助于评估这些系统的亚临床变化。